Cutting edge: FimH adhesin of type 1 fimbriae is a novel TLR4 ligand

Journal of Immunology

Volumn 181, Issue 10, 2008, Pages 6702-6706

  Mossman, Karen L ^a   Mian, M Firoz ^a   Lauzon, Nicole M ^a   Gyles, Carlton L ^b   Lichty, Brian ^a   Mackenzie, Randy ^a   Gill, Navkiran ^a   Ashkar, Ali A ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; CD14 ANTIGEN; FIMH ADHESIN; LIGAND; LIPOPOLYSACCHARIDE; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN MD 2; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; FIMBRIA PROTEIN; FIMH PROTEIN, E COLI;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FIMBRIA; GRAM NEGATIVE INFECTION; HUMAN; HUMAN CELL; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANIMAL; CELL LINE; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; IMMUNOLOGY; MACROPHAGE ACTIVATION; METABOLISM; MOUSE; PERITONEUM MACROPHAGE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADHESINS, ESCHERICHIA COLI; ANIMALS; CELL LINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLASTS; FIMBRIAE PROTEINS; HUMANS; LIGANDS; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MICE; MYELOID DIFFERENTIATION FACTOR 88; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TOLL-LIKE RECEPTOR 4;

EID: 58149181986     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.10.6702     Document Type: Article

References (19)

1. Kaisho, T., and S. Akira. 2001. Toll-like receptors and their signaling mechanism in innate immunity. Acta Odontol. Scand. 59: 124-130. (Pubitemid 33644360)
2. Beutler, B. 2004. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430: 257-263. (Pubitemid 38902439)
3. Klemm, P., M. Schembri, and D. L. Hasty. 1996. The FimH protein of type 1 fimbriae. An adaptable adhesin. Adv. Exp. Med. Biol. 408: 193-195. (Pubitemid 26331069)
4. Meiland, R., S. E. Geerlings, S. Langermann, E. C. Brouwer, F. E. Coenjaerts, and A. I. Hoepelman. 2004. Fimch antiserum inhibits the adherence of Escherichia coli to cells collected by voided urine specimens of diabetic women. J. Urol. 171: 1589-1593. (Pubitemid 38365427)
5. Connell, I., W. Agace, P. Klemm, M. Schembri, S. Marild, and C. Svanborg. 1996. Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. Proc. Natl. Acad. Sci. USA 93: 9827-9832.
6. Fischer, H., M. Yamamoto, S. Akira, B. Beutler, and C. Svanborg. 2006. Mechanism of pathogen-specific TLR4 activation in the mucosa: fimbriae, recognition receptors and adaptor protein selection. Eur. J. Immunol. 36: 267-277. (Pubitemid 43257449)
7. Wizemann, T. M., J. E. Adamou, and S. Langermann. 1999. Adhesins as targets for vaccine development. Emerg. Infect. Dis. 5: 395-403.
8. Kariyawasam, S., B. N. Wilkie, and C. L. Gyles. 2004. Resistance of broiler chickens to Escherichia coli respiratory tract infection induced by passively transferred egg-yolk antibodies. Vet. Microbiol. 98: 273-284. (Pubitemid 38224496)
9. Paladino, P., D. T. Cummings, R. S. Noyce, and K. L. Mossman. 2006. The IFN-independent response to virus particle entry provides a first line of antiviral defense that is independent of TLRs and retinoic acid-inducible gene I. J. Immunol. 177: 8008-8016. (Pubitemid 44846318)
10. Lee, J., S. Shin, C. H. Teng, S. J. Hong, and K. S. Kim. 2005. FimH adhesin of Escherichia coli K1 type 1 fimbriae activates BV-2 microglia. Biochem. Biophys. Res. Commun. 334: 917-923. (Pubitemid 41033207)
11. Zhang, D., G. Zhang, M. S. Hayden, M. B. Greenblatt, C. Bussey, R. A. Flavell, and S. Ghosh. 2004. A Toll-like receptor that prevents infection by uropathogenic bacteria. Science 303: 1522-1526. (Pubitemid 38314423)
12. Miyake, K., Y. Nagai, S. Akashi, M. Nagafuku, M. Ogata, and A. Kosugi. 2002. Essential role of MD-2 in B-cell responses to lipopolysaccharide and Toll-like receptor 4 distribution. J. Endotoxin Res. 8: 449-452. (Pubitemid 36104599)
13. Nagai, Y., S. Akashi, M. Nagafuku, M. Ogata, Y. Iwakura, S. Akira, T. Kitamura, A. Kosugi, M. Kimoto, and K. Miyake. 2002. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat. Immunol. 3: 667-672. (Pubitemid 34752476)
14. Shimazu, R., S. Akashi, H. Ogata, Y. Nagai, K. Fukudome, K. Miyake, and M. Kimoto. 1999. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189: 1777-1782. (Pubitemid 29272694)
15. Kawasaki, K., H. Nogawa, and M. Nishijima. 2003. Identification of mouse MD-2 residues important for forming the cell surface TLR4-MD-2 complex recognized by anti-TLR4-MD-2 antibodies, and for conferring LPS and Taxol responsiveness on mouse TLR4 by alanine-scanning mutagenesis. J. Immunol. 170: 413-420. (Pubitemid 36026166)
16. Jones, C. H., J. S. Pinkner, R. Roth, J. Heuser, A. V. Nicholes, S. N. Abraham, and S. J. Hultgren. 1995. FimH adhesin of type 1 pili is assembled into a fibrillar tip structure in the Enterobacteriaceae. Proc. Natl. Acad. Sci. USA 92: 2081-2085.
17. Klemm, P., and G. Christiansen. 1987. Three fim genes required for the regulation of length and mediation of adhesion of Escherichia coli type 1 fimbriae. Mol. Gen. Genet. 208: 439-445.
18. Wellens, A., C. Garofalo, H. Nguyen, N. Van Gerven, R. Slattegard, J. P. Hernalsteens, L. Wyns, S. Oscarson, H. De Greve, S. Hultgren, and J. Bouckaert. 2008. Intervening with urinary tract infections using anti-adhesives based on the crystal structure of the FimH-oligomannose-3 complex. PLoS ONE 3: e2040. (Pubitemid 352024766)
19. Abreu, M. T., L. S. Thomas, E. T. Arnold, K. Lukasek, K. S. Michelsen, and M. Arditi. 2003. TLR signaling at the intestinal epithelial interface. J. Endotoxin Res. 9: 322-330.